SEC Form 4 · accession 0001140361-15-007866
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacqueline Studer
Officer — CVP, Gen. Counsel & Secretary
Period of report
Feb 14, 2015
Accepted (ET)
Feb 18, 2015 · 6:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $159.08 | Feb 14, 2015 | A | 7,165 | A | — | Feb 13, 2025 | Common Stock | 7,165 | 7,165 | D |
| Incentive Stock Option (right to buy)F2 | $159.08 | Feb 14, 2015 | A | 3,140 | A | — | Feb 13, 2025 | Common Stock | 3,140 | 3,140 | D |
| Restricted Stock UnitF3 | — | Feb 14, 2015 | A | 864 | A | — | — | Common Stock | 864 | 3,687 | D |
Explanation of responses
- F1Grant of option to buy shares of common stock that vests in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.
- F2Grant of option to buy shares of common stock that vests in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.
- F3Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.